Aims: Low birth weight is associated with hypothyroidism and an adverse metabolic profile in later life. Our aim was to examine the relationship between neonatal TSH and birth weight, gestational age and sex. Methods: We compared blood spot filter paper TSH levels with birth weight, gestational age and sex in a 10% sample of infants screened for congenital hypothyroidism at a single centre in Northern England. All gestational ages were included with infants suspected of having congenital hypothyroidism excluded. Results: Data on 1,728 male and 1,662 female infants were analysed. The distribution of TSH was significantly different between males and females, with males having a higher median TSH (0.7 vs. 0.6). Correlations were shown between TSH and birth weight (ρ = –0.07, p = 0.0001) and gestational age (ρ = –0.05, p = 0.008), with the birth weight association remaining independent of gestational age. The functional form of the model suggested that higher TSH in the lowest birth weight categories was responsible for the association between TSH and birth weight. Conclusions: Low birth weight is related to neonatal TSH levels. Further research is required to assess whether this association explains the relationship between higher TSH and an adverse metabolic profile in later life.

1.
Barker DJ, Osmond C, Golding J, Kuh D, Wadsworth ME: Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease. BMJ 1989;298:564–567.
2.
Barker DJ: Fetal origins of coronary heart disease. BMJ 1995;311:171–174.
3.
Murphy N, Hume R, van Toor H, Matthews TG, Ogston SA, Wu SY, Visser TJ, Williams FL: The hypothalamic-pituitary-thyroid axis in preterm infants; changes in the first 24 hours of postnatal life. J Clin Endocrinol Metab 2004;89:2824–2831.
4.
LaFranchi S: Thyroid function in the preterm infant. Thyroid 1999;9:71–78.
5.
Herbstman J, Apelberg BJ, Witter FR, Panny S, Goldman LR: Maternal, infant, and delivery factors associated with neonatal thyroid hormone status. Thyroid 2008;18:67–76.
6.
Radetti G, Renzullo L, Gottardi E, D’Addato G, Messner H: Altered thyroid and adrenal function in children born at term and preterm, small for gestational age. J Clin Endocrinol Metab 2004;89:6320–6324.
7.
Roos A, Bakker SJL, Links TP, Gans ROB, Wolffenbuttel BHR: Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007;92:491–496.
8.
Andersen S, Pedersen KM, Bruun NH, Laurberg P: Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002;87:1068–1072.
9.
Pryce RA, Gregory JW, Warner JT, John R, Bradley D, Evans C: Is the current threshold level for screening for congenital hypothyroidism too high? An audit of the clinical evaluation, confirmatory diagnostic tests and treatment of infants with increased blood spot thyroid-stimulating hormone concentrations identified on newborn blood spot screening in Wales. Arch Dis Child 2007;92:1048.
10.
Korada M, Pearce M, Ward-Platt M, Avis E, Turner S, Wastell H, Cheetham T: Repeat testing for congenital hypothyroidism in preterm infants: unnecessary with an appropriate TSH threshold. Arch Dis Child 2008;93:F286–F288.
11.
LePage J, Peters S, Lehotay DC: Assay of neonatal TSH from blood spots using the Architect i2000, an immunoassay analyzer. Clin Chem 2004;37:415–417.
12.
Royston P, Ambler G, Sauerbrei W: The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999;28:964–974.
13.
Ng SM, Wong SC, Paize F, Chakkarapani E, Newland P, Isherwood DM, Didi M: Delay in screening premature infants for congenital hypothyroidism. Arch Dis Child 2006;91:F465–F466.
14.
Arends NJ, Boonstra VH, Duivenvoorden HJ, Hofman PL, Cutfield WS, Hokken-Koelega AC: Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age. Clin Endocrinol 2005;62:44–50.
15.
Åsvold BO, Vatten LJ, Nilsen TIL, Bjøro T: The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 2007;156:181–186.
16.
Fernández-Real J, López-Bermejo A, Castro A, Casamitjana R, Ricart W: Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab 2006;91:3337–3343.
17.
Pearce MS, Unwin NC, Relton C, Alberti KGMM, Parker L: Lifecourse determinants of fasting and post-challenge glucose at age 50 years: the Newcastle Thousand Families Study. Eur J Epidemiol 2005;20:915–923.
18.
Pearce MS, Unwin NC, Parker L, Alberti KGMM: Life course determinants of insulin secretion and sensitivity at age 50 years: the Newcastle Thousand Families Study. Diabetes Metab Res Rev 2006;22:118–125.
19.
Kajantie E, Phillips DIW, Osmond C, Barker DJP, Forsén T, Eriksson JG: Spontaneous hypothyroidism in adult women is predicted by small body size at birth and during childhood. J Clin Endocrinol Metab 2006;91:4953–4956.
20.
McDade TW, Beck MA, Kuzawa CW, Adail LS: Prenatal undernutrition and postnatal growth are associated with adolescent thymic function. J Nutr 2001;131:1225–1231.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.